TargetMol

Reproterol hydrochloride

Product Code:
 
TAR-T28519
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T28519-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28519-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28519-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Reproterol hydrochloride, a β2 adrenoreceptor agonist, is used to treat asthma and chronic obstructive pulmonary disease (COPD).
CAS:
13055-82-8
Formula:
C18H24ClN5O5
Molecular Weight:
425.87
Purity:
0.98
SMILES:
Cl.Cn1c2ncn(CCCNCC(O)c3cc(O)cc(O)c3)c2c(=O)n(C)c1=O

References

1. K?pper T, Goebbels K, Kennes LN, Netzer NC. Cromoglycate, reproterol, or both--what's best for exercise-induced asthma? Sleep Breath. 2012 Dec;16(4):1229-35. doi: 10.1007/s11325-011-0638-2. Epub 2011 Dec 27. PubMed PMID: 22198635. 2. Alvarez-Guerra M, Libertus H, Garay RP. Inhibition by reproterol of cAMP PDE in intact mastocytoma P-815 cells. Pulm Pharmacol Ther. 2004;17(4):213-8. PubMed PMID: 15219266. 3. Eleno N, Gajate E, Macias J, Garay RP. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes. Pulm Pharmacol Ther. 1999;12(1):55-60. PubMed PMID: 10208836. 4. Juergens UR, St?ber M, Vetter H. Reproterol--A monomolecular combination of orciprenaline and theophylline: novel aspects of its mode of action in asthma. Respiration. 1999;66(3):220-4. PubMed PMID: 10364737.